Search results for: 'software energy ai dosag analyst'
- Related search terms
- Software License Management Market
- Energy Efficiency Series - Waste To Energy - Biological and Thermal Treatment
- energy level drone market size
- analyst market
- dosag health market
-
21 Jun 2018  |  North America  |  Market Research
Endoscope Reprocessing Systems and Software Solutions Market Assessment, United States, Forecast to 2022
Despite Reaching Near Saturation, the Market will Grow at Healthy Rate Driven by High Procedural Volume Growth Coupled with Consistently High Replacements and Newer Installations
Endoscope reprocessing systems and workflow solutions was a $526.6 million market in the United States in 2017. It is expected to grow at healthy CAGR of 8.6% to reach $796.4 million in 2022. The market is segmented into two broad segments which are then divided into several sub-segments as mentioned below: • Endoscope reprocessing solutions ...
$4,950.00
Special Price $3,712.50 save 25 %
-
23 Jan 2026  |  Global  |  Technology Research
Next-Generation Therapeutic Platforms: AI-Enabled Drug Discovery, Small molecules, Deep Proteomics, RNA Engineering, and Targeted Immunomodulation
Life Science, Health & Wellness Technology Opportunity Engine
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) delivers provides strategic insights into breakthrough innovations shaping the future of healthcare, life sciences, and precision therapeutics. It highlights advances in AI-enabled diagnostics, metabolic reprogramming, small molecules, deep proteomics, RNA disco...
$950.00 -
12 Jan 2026  |  Global  |  Frost Radar
Frost Radar™: Artificial Intelligence-Enabled Clinical Trials, 2026
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
Artificial intelligence (AI) has been revolutionizing the technology-enabled drug discovery and development landscape. In clinical research, AI has been gaining traction across site selection, trial design and protocol optimization, and patient recruitment and management. Because data is the core discipline of drug development, electronic medical r...
$4,950.00 -
17 Jul 2026  |  Global  |  Technology Research
Innovations and Growth Opportunities in AI-Driven Drug Discovery, Precision Diagnostics, Advanced Biologics, and Next-generation Vaccines
Life Science, Health & Wellness Technology Opportunity Engine
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping drug discovery, diagnostics, and therapeutic delivery across oncology, infectious diseases, rare and autoimmune disorders, metabolic and age-related conditions, neurodegenerative and neuromu...
$950.00 -
26 Sep 2019  |  Global  |  Market Research
Growth Insight—Role of AI in the Pharmaceutical Industry, Global, 2018–2022
Exploring Key Investment Trends, Companies-to-Action, and Growth Opportunities for AI in the Pharmaceutical Industry
Pharmaceutical drug discovery and development processes suffer from declining success rates and a stagnant pipeline. Artificial Intelligence (AI) supported by Big Data could be a key element that can provide an effectual solution. There has been a rapid growth in the data generated within the life sciences and pharmaceutical industries. This stems ...
$4,950.00
Special Price $3,712.50 save 25 %
-
30 Jul 2026  |  Global  |  Frost Radar
Frost Radar™: Life Sciences Regulatory Information Management Platforms, 2026
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
The regulatory technology market in life sciences has, over the last five years, quietly transformed from a back-office category dominated by document repositories and submission publishing tools to one of the most consequential software segments serving the pharmaceutical, biotech, and medical device industries. What started in the late 1990s as a...
$4,950.00 -
27 Jun 2018  |  North America  |  Market Research
Endoscope Reprocessing Systems and Software Solutions Market Assessment, Australia, Forecast to 2022
The Market for Endoscope Reprocessing Solutions Would be Driven by Increasing Procedural Volumes, Coupled with Increased Demand for Newer Installations as Well as Replacements
The market for endoscope reprocessing systems and workflow solutions in Australia was worth A$61.1 million in 2017. It is expected to grow at a robust CAGR of 10.1% to reach a market size of A$98.7 million in 2022. The market is segmented into two broad segments, which are then divided into several sub-segments as mentioned below – • Endoscope r...
$4,950.00
Special Price $3,712.50 save 25 %
-
11 Jan 2019  |  Europe  |  Market Research
Integrated Practice Management Software (IPMS) Market—Primary Care IT 2.0 in Europe, Forecast to 2022
IPMS to Elevate Primary Care IT and Meet the Goals of Integrated Care
There is a high demand for more efficiency of time and resources in General Physician (GP) practices that are extremely strained under the increasing chronic disease burden and decreasing staff numbers. There is also increasing reliance on healthcare information technology, driven by a supportive regulatory environment, and it is contributing to a ...
$4,950.00
Special Price $3,712.50 save 25 %
-
22 Aug 2018  |  Europe  |  Market Research
Western European Endoscope Reprocessing Systems and Software Solutions Market Assessment, Forecast to 2022
Increasing Day-care Facilities, Ongoing and Planned "Mega Hospitals", and Continued Hospital Consolidation Coupled With Procedural Volume Growth Will Drive the Market
Endoscope reprocessing systems and workflow solutions was a €416.4 million market in the top five Western European countries (UK, Germany, France, Spain, and Italy) in 2017. It is expected to grow at a robust CAGR of 9.5% to reach a revenue of €654.9 million by 2022. The market is segmented into two broad segments which are then divided into severa...
$4,950.00
Special Price $3,712.50 save 25 %
-
17 Apr 2026  |  Global  |  Technology Research
Innovations and Growth Opportunities in Advanced Biologic Therapies, AI-powered Diagnostics, Drug Delivery Platforms, and Precision Medicine
Life Science, Health & Wellness Technology Opportunity Engine
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping diagnostics, therapeutics, and clinical workflows across infectious diseases, women’s health, metabolic disorders, neurodegeneration, oncology, rare diseases, and musculoskeletal care. It hi...
$950.00